|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Potential future therapies: natriuretic peptides 显示文摘 | BURNETT J C Jr | 1999 | Coron Artery Dis1999，10，9： | 1 |
| 2 | A pilot study of dendroaspis natriuretic vasoactive and natriuretic peptide , dendroaspis natriuretic peptide , in experimental severe congestive heart failure显示文摘 | Lisy O Lainchbuty JG Leskinen H | 2001 | Hypertension2001，37，1： | 1 |
| 3 | Measurement of in vivo lumbar intervertebral disc pressure during spinal manipulation:a feasibility study显示文摘 | Lisi AJ O'Neill CW Lindsey DP | 2006 | J Appl Biomech2006，22，3： | 1 |
| 4 | Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure显示文摘 | Lisy O Lainchbury JG Leskinen H | 2001 | Hypertension2001，37，4： | 1 |
| 5 | Time course d endothelin - 1 plasma level in patients with acute coronary syndromes显示文摘 | Vojacek J Kolar J Lisy O | 1999 | Cardiology1999，91，： | 1 |
| 6 | Obesity-associated hepatosteatosis and impairment of glucose homeostasis are attenuated by haptoglobin deficiency显示文摘 | Lisi S Gamucci O Vottari T | 2011 | Diabetes2011，60，10： | 1 |
| 7 | Therapeutic actions of a new synthetic vasoactive aM natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure 显示文摘 | Lisy O Lainchbury JG Leskinen H | 2001 | Hypertension2001，37，4： | 1 |
| 8 | Potential future therapies:natriuretic peptides显示文摘 | Burnettjc Jr | 1999 | Coron Artery Dis1999，10，： | 1 |
| 9 | Pharmacodynamies of a novel designer natriuretic peptide, CD-NP,in a first-in-human clinical trial in healthy subjects显示文摘 | Lee CY Chert HH Lisy O | 2009 | J Clin Pharmacol2009，49，6： | 1 |
| 10 | Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin显示文摘 | Lisy O Jougasaki M Schirger JA | 1998 | Am J Physiol1998，275，32： | 1 |
| 11 | Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin显示文摘 | Lisy O Jougasaki M Schirger JA | 1998 | Am J Physiol1998，275，32： | 1 |
| 12 | Therapeutic actions of a new synthetic vasoative and natriuretic peptide,dendroaspis natriuretic peptide, in experimental severe congestive heart failure 显示文摘 | Lisy O Eainchbury JG Lesniken H | 2001 | Hypertension2001，37，4： | 1 |
| 13 | Therapeutic actions of a new synthetic vasoactive and natriuretlc peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure 显示文摘 | Lisy O Lainchbury JG Leskinen H | 2001 | Hypertension2001，37，4： | 1 |
| 14 | Time course of endothelin-1 plasma level in patients with acute coronary syndromes显示文摘 | Vojacek J Kolar J Lisy O | 1999 | Cardiology1999，91，2： | 1 |
| 15 | Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention显示文摘 | Schirger JA Chen HH Jougasaki M Lisy O Boerrigter G Cataliotti A Burnett JC | 2004 | Circulation2004，109，： | 1 |
| 16 | Time course of endothelin-Ⅰ plasma level in patients with acute coronary syndrome显示文摘 | Vojacek J Kolar J Lisy O | 1999 | Cardiology1999，91，2： | 1 |
| 17 | Time course of endothelin-1 plasma level in patients with acute coronary syndromes显示文摘 | Vojacek J Kolar J Lisy O | 1999 | Cardiology1999，91，2： | 1 |
| 18 | Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure 显示文摘 | Lisy O Lainchbury J G Leskinen H | 2001 | Hypertension2001，37，4： | 1 |
| 19 | Therapeutic actions of a new synthetic vasovctive and natriuretic peptide,dendroaspis natriuretic peptide,in experimental severe congestive heart failure显示文摘 | Lainchbury JG Lesniken H | 2001 | Hypertension2001，37，： | 1 |
| 20 | Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure 显示文摘 | LAINCHBURY J G LESKINEN H | 2001 | Hypertension2001，37，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员